Genesis AI
About Genesis AI
Genesis AI is a Robotics startup based in Paris, France that has raised $105M in venture capital across 1 funding round since 2024. The company reached Seed stage in July 2025 with a $105M round led by Eclipse Ventures. Genesis AI's investor base includes 5 institutional funds, with Eclipse Ventures leading the most recent equity round.
Genesis AI builds physical AI infrastructure for general-purpose robots. Its flagship product, GENE, is a full-stack robotics foundation model that gives robots the ability to see, reason, and manipulate objects with human-level dexterity. The company pairs this robot brain with a proprietary human-scale dexterous robotic hand and a data engine that generates unlimited synthetic training data through physics simulation, enabling direct transfer of human manipulation skills to robots for industrial applications including manufacturing, logistics, agriculture, and laboratory automation. Founded in December 2024 by Carnegie Mellon researchers Zhou Xian and Théophile Gervet — formerly of Mistral AI — Genesis AI is incorporated as a French SAS with offices in Silicon Valley and London.
Genesis AI Funding Rounds Timeline
1 rounds · $105M raised · since 2024
| Round | Date | Amount | Valuation | Lead investor | Co-investors |
|---|---|---|---|---|---|
| Seed | July 2025 | $105M | — | Eclipse Ventures | Khosla Ventures, Bpifrance, HSG, HongShan |
Investors in Genesis AI
5 institutional investors across 1 rounds
Lead investors
Co-investors
Recent news about Genesis AI
Questions about Genesis AI
How much has Genesis AI raised?
Genesis AI has raised $105M across 1 funding round since 2024.
Who are the investors of Genesis AI?
Genesis AI's investors include Eclipse Ventures, Khosla Ventures, Bpifrance, HSG, HongShan.
When was Genesis AI's last funding round?
Genesis AI's most recent round was a $105M Seed in July 2025, led by Eclipse Ventures.
Where is Genesis AI headquartered?
Genesis AI is headquartered in Paris, France, and was founded in 2024 by Zhou Xian, Théophile Gervet.